Immune response to hepatitis B vaccine in health-care workers. 2011

Farhad Zamani, and Farahnaz Fallahian, and Forough Hashemi, and Zeinab Shamsaei, and Seyed-Moayed Alavian
Gastroenterintestinal and Liver Disease Research Center, Iran University of Medical Sciences, Tehran, Iran. zamani.farhad@gmail.com

This study was performed to study the immune response to hepatitis B virus (HBV) vaccine in health-care workers. Through a cross-sectional study, relevant information and blood samples from 151 healthcare workers at the Firuzgar hospital were studied. The age range of the study individuals was 20-59 years, with the mean and standard deviation being 35.11 and 10.06, respectively. There were 24 males (15.9%) and 127 females (84.1%). The mean and median of months after HBV vaccination was 63.42 and 49.00, respectively. The mean and median of anti-HBs titer in those who received HBV vaccination was 164.81 and 200 milli international units per milliliter (mIU/mL), respectively. Of the 129 HBV-vaccinated subjects, 103 (68.2%) had anti-HBs titer >10 and 26 (17.2%) had anti-HBs titer <10. There was no association between gender and anti-HBs titer, but vaccination and adequate completion of its courses were associated with higher anti-HBs titer (P < 0.05). Also, the logistic regression method showed that the association between duration after vaccination and age with anti-HBs titer was not statistically significant. Our study suggests that the HBV vaccine immunization program had obtained excellent efficacy. There is need for further investigation among subjects who are not vaccinated against HBV but are positive for anti-HBs as well as in HBV-vaccinated subjects with low anti-HBs titers, about possible low-level viremia and other causes of lower vaccine efficacy, particularly in health-care workers.

UI MeSH Term Description Entries
D007492 Iran A country bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. The capital is Tehran. Islamic Republic of Iran
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006282 Health Personnel Men and women working in the provision of health services, whether as individual practitioners or employees of health institutions and programs, whether or not professionally trained, and whether or not subject to public regulation. (From A Discursive Dictionary of Health Care, 1976) Health Care Professionals,Health Care Providers,Healthcare Providers,Healthcare Workers,Health Care Professional,Health Care Provider,Healthcare Provider,Healthcare Worker,Personnel, Health,Professional, Health Care,Provider, Health Care,Provider, Healthcare
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Farhad Zamani, and Farahnaz Fallahian, and Forough Hashemi, and Zeinab Shamsaei, and Seyed-Moayed Alavian
November 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Farhad Zamani, and Farahnaz Fallahian, and Forough Hashemi, and Zeinab Shamsaei, and Seyed-Moayed Alavian
January 1987, The Journal of infection,
Farhad Zamani, and Farahnaz Fallahian, and Forough Hashemi, and Zeinab Shamsaei, and Seyed-Moayed Alavian
February 1998, Hepatology (Baltimore, Md.),
Farhad Zamani, and Farahnaz Fallahian, and Forough Hashemi, and Zeinab Shamsaei, and Seyed-Moayed Alavian
July 2011, The Southeast Asian journal of tropical medicine and public health,
Farhad Zamani, and Farahnaz Fallahian, and Forough Hashemi, and Zeinab Shamsaei, and Seyed-Moayed Alavian
March 2011, Vaccine,
Farhad Zamani, and Farahnaz Fallahian, and Forough Hashemi, and Zeinab Shamsaei, and Seyed-Moayed Alavian
January 2018, Indian journal of medical microbiology,
Farhad Zamani, and Farahnaz Fallahian, and Forough Hashemi, and Zeinab Shamsaei, and Seyed-Moayed Alavian
October 1986, American journal of clinical pathology,
Farhad Zamani, and Farahnaz Fallahian, and Forough Hashemi, and Zeinab Shamsaei, and Seyed-Moayed Alavian
October 1998, Hepatology (Baltimore, Md.),
Farhad Zamani, and Farahnaz Fallahian, and Forough Hashemi, and Zeinab Shamsaei, and Seyed-Moayed Alavian
October 2007, BMC infectious diseases,
Farhad Zamani, and Farahnaz Fallahian, and Forough Hashemi, and Zeinab Shamsaei, and Seyed-Moayed Alavian
January 1996, Medical care,
Copied contents to your clipboard!